Sharps Technology, Inc. (STSS)
USD 4.75
(-9.35%)
USD 4.75
(-9.35%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -10.12 Million USD | -15.88% |
| 2022 | -8.73 Million USD | -94.3% |
| 2021 | -4.49 Million USD | -92.75% |
| 2020 | -2.33 Million USD | -13.32% |
| 2019 | -2.05 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -1.84 Million USD | 36.81% |
| 2024 Q2 | -1.92 Million USD | -4.18% |
| 2023 Q4 | -2.91 Million USD | -23.74% |
| 2023 FY | -10.12 Million USD | -15.88% |
| 2023 Q2 | -2.53 Million USD | -9.26% |
| 2023 Q3 | -2.35 Million USD | 6.87% |
| 2023 Q1 | -2.31 Million USD | 17.71% |
| 2022 Q4 | -2.81 Million USD | -56.74% |
| 2022 Q3 | -1.79 Million USD | 35.53% |
| 2022 Q2 | -2.78 Million USD | -108.46% |
| 2022 Q1 | -1.33 Million USD | 6.51% |
| 2022 FY | -8.73 Million USD | -94.3% |
| 2021 Q1 | -915.14 Thousand USD | -7.47% |
| 2021 FY | -4.49 Million USD | -92.75% |
| 2021 Q3 | -1.34 Million USD | -65.41% |
| 2021 Q2 | -810.88 Thousand USD | 11.39% |
| 2021 Q4 | -1.43 Million USD | -6.64% |
| 2020 Q4 | -851.53 Thousand USD | -38.05% |
| 2020 Q3 | -616.81 Thousand USD | 0.0% |
| 2020 FY | -2.33 Million USD | -13.32% |
| 2019 FY | -2.05 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Akoya Biosciences, Inc. | -57.66 Million USD | 82.44% |
| AngioDynamics, Inc. | -97.71 Million USD | 89.637% |
| AtriCure, Inc. | -26.68 Million USD | 62.048% |
| Avinger, Inc. | -16.63 Million USD | 39.124% |
| Azenta, Inc. | -73.12 Million USD | 86.152% |
| BioLife Solutions, Inc. | -70.82 Million USD | 85.702% |
| The Cooper Companies, Inc. | 533.1 Million USD | 101.9% |
| Daxor Corporation | -177.07 Thousand USD | -5618.848% |
| Ekso Bionics Holdings, Inc. | -15.11 Million USD | 32.989% |
| Femasys Inc. | -14.5 Million USD | 30.202% |
| GlucoTrack, Inc. | -7.1 Million USD | -42.549% |
| Harvard Bioscience, Inc. | 1.89 Million USD | 634.67% |
| Hologic, Inc. | 882.6 Million USD | 101.147% |
| ICU Medical, Inc. | 22.82 Million USD | 144.366% |
| Intuitive Surgical, Inc. | 1.76 Billion USD | 100.573% |
| KORU Medical Systems, Inc. | -10.26 Million USD | 1.396% |
| LeMaitre Vascular, Inc. | 37.08 Million USD | 127.309% |
| Innovative Eyewear, Inc. | -6.9 Million USD | -46.752% |
| Innovative Eyewear, Inc. | -6.9 Million USD | -46.752% |
| Masimo Corporation | 136.5 Million USD | 107.419% |
| Microbot Medical Inc. | -9.85 Million USD | -2.756% |
| Meihua International Medical Technologies Co., Ltd. | 14.67 Million USD | 169.006% |
| Merit Medical Systems, Inc. | 123.94 Million USD | 108.17% |
| Nephros, Inc. | -1.59 Million USD | -535.697% |
| NovoCure Limited | -232.87 Million USD | 95.651% |
| NEXGEL, Inc. | -3.47 Million USD | -191.247% |
| NEXGEL, Inc. | -3.47 Million USD | -191.247% |
| Singular Genomics Systems, Inc. | -102.8 Million USD | 90.149% |
| OraSure Technologies, Inc. | 54.07 Million USD | 118.726% |
| Pro-Dex, Inc. | 7.17 Million USD | 241.177% |
| Pulse Biosciences, Inc. | -43.57 Million USD | 76.76% |
| Predictive Oncology Inc. | -13.92 Million USD | 27.258% |
| Precision Optics Corporation, Inc. | -2.72 Million USD | -271.711% |
| QuidelOrtho Corporation | 139.1 Million USD | 107.28% |
| Repligen Corporation | 54.57 Million USD | 118.555% |
| Sanara MedTech Inc. | -4.21 Million USD | -140.244% |
| STAAR Surgical Company | 28.09 Million USD | 136.042% |
| Utah Medical Products, Inc. | 16.77 Million USD | 160.36% |
| DENTSPLY SIRONA Inc. | -85 Million USD | 88.086% |
| Jin Medical International Ltd. | 2.86 Million USD | 453.182% |